| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.693 | 55.551 | 70.443 | 17.087 | 1.086 | 0 |
| Total Income - EUR | - | - | - | - | 2.693 | 55.570 | 70.459 | 19.066 | 1.138 | 0 |
| Total Expenses - EUR | - | - | - | - | 1.312 | 37.217 | 48.927 | 16.948 | 2.814 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.381 | 18.353 | 21.533 | 2.119 | -1.675 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | 1.300 | 17.460 | 20.970 | 1.885 | -1.675 | 0 |
| Employees | - | - | - | - | 0 | 2 | 3 | 1 | 0 | 0 |
Check the financial reports for the company - Gemifarma Plant S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 1.423 | 20.586 | 40.257 | 26.002 | 25.824 | 25.679 |
| Inventories | - | - | - | - | 122 | 422 | 1.046 | 687 | 702 | 698 |
| Receivables | - | - | - | - | 362 | 4.681 | 596 | 867 | 21.158 | 21.040 |
| Cash | - | - | - | - | 939 | 15.484 | 38.614 | 24.447 | 3.964 | 3.942 |
| Shareholders Funds | - | - | - | - | 1.342 | 17.522 | 38.103 | 23.884 | 22.137 | 22.013 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 81 | 3.064 | 2.153 | 2.117 | 3.687 | 3.666 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Gemifarma Plant S.r.l.